Expression of BCL-2 oncoprotein on tumor cells and tumor-infiltrating lymphocytes (TIL) in meningiomas

Neurosurgical Review

Volumn 22, Issue 4, 1999, Pages 205-209

  Roessler, Karl ^a   Dietrich, Wolfgang ^a   Kitz, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

BCL 2 oncoprotein; Ki67 index; Meningiomas; Tumor infiltrating lymphocytes (TIL)

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL COUNT; CELL SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

EID: 0033402504     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101430050017     Document Type: Article

References (31)

1. Batistatu A, Merry DE, Korsemeyer SJ, Greene LA (1993) BCL-2 affects survival but not neuronal differentiation of PC12 cells. J Neurosci 13:4422-4428
2. Becker I, Roggendorf W (1989) immunohistochemical investigation of mononuclear cell infiltrates in meningiomas. Acta Neuropathol (Berl) 79:211-216
3. Bo L, Mork SJ, Nyland H (1992) An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18:548-558
4. Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative activity of human brain tumors using the monoclonal antibody Ki67. J Cancer Res Clin Oncol 115: 179-188
5. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne W, Hartley JA, Dive C, Hickman JA (1993) BCL-2 modulation of apoptosis induced by anticancer drugs. Resistance to thymidylate stress is dependent on classic resistance pathways. Cancer Res 51:3321-3326
6. Gerdes J, Lewe H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell-proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710-1715
7. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H (1987) Growth fraction in human brain tumors defined by the monoclonal antibody Ki67. Acta Neuropathol (Berl) 74: 179-182
8. Hanada M, Krajewski S, Tanaka S, Casals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC (1993) Regulation of BCL-2 oneoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978-4986
9. Hara A, Hirose Y, Yoshimi N, Tanaka T, Mori H (1997) Expression of Bax and BCL-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 19 (6):623-628
10. Hockenbery DIVI, Nunez G, Milliman C, Schreiber RD, Korsemeyer SJ (1993) BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
11. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) BCL-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-369
12. Knosp E, Kitz K, Pernewky A (1989) Proliferation activity in pituitary adenomas: measurement by mononuclear antibody Ki. Neurosurgery 25:927-930
13. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of M113-1, p53, and BCL-2 immunoreactivity in meningiomas. Hum Pathol 29 (2): 140-145
14. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin
15. Krishna M, Smith TW, Rect LD (1995) Expression of BCL-2 in reactive and neoplastic astrocytes: lack of correlation to presence or degree of malignancy. J Neurosurg 83:1017
16. Leoncini L, Del Veccio MT, Megha T, Barbini P, Galieni P, Pileri S, Sabattini E, Gherlinzoni F, Tosi P, Kraft R, Cottier H (1993) Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142: 755-763
17. Maier H, Wanschitz J, Sedivy R, Rossler K, Ofner D, Budka H (1997) Proliferation and DNA fragmentation in meningioma subtypes. Neuropathol Applied Neurobiol 23:496-506
18. Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumors. Acta Neuropathol (Berl) 77:276
19. Moisnier JIF, Perret AG, Brunon J, Boucheron S (1996) Expression of BCL-2 oncoprotein in meningiomas. Am J Clin Pathol 106 (5):652-659
20. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J (1994) BCL-2 protein expression in tumors of the central nervous system. Acta Neuropathol (Berl) 88:520-526
21. Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T (1996) Expression of BCL-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 45 (3):230-235
22. Ostertag CB, Volk B, Shibata T, Burger P, Kleihues P (1987) The monoclonai antibody Ki67 as a marker for proliferating cells in stereotactic biopsies in brain tumors. Acta Neurochir (Wien) 89:117-121
23. Patsouris E, Stocker U, Kallmeyer V, Keotsch E, Mehraein P, Stavrou D (1988) Relationship between Ki67-positive cells, growth rate, and histological type of human intracranial tumors. Anticancer Res 8:537-544
24. Reifenberger G, Deckert M, Wechsler W (1989) Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors. Acta Neuropathol (Berl) 78:166-175
25. Roessler K, Suchanek G, Breitschopf H, Kitz K, Matula C, Lassmann H, Koos WT (1995) Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridisation using molecular probes. J Neurosurg 83:291-297
26. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB (1987) Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol (Berl) 74: 269-277
27. Rossi ML, Cruz Sanchez F, Hughes JT, Esiri MM, Coakham HB (1988) Immunocytochemical study of the cellular immune response in meningiomas. J Clin Pathol 41:314
28. Schiffer D, Cavalla P, Mighell A, Giordana MT, Chiado-Piat L (1996) Bel-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neurooncol 27 (2):101-109
29. Sentmen CL, Shutter JR, Hockenberry D, Kanagawa O, Korsemeyer SJ (1991) BCL-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888
30. Strasser A, Harris AW, Cory S (1991) BCL-2 transgene inhibits T cell death and perturbs thymic cell censorship. Cell 67: 889-899
31. Walton MI, Whysong D, O'Connor PM, Hockenberry D, Korsemeyer SJ, Kohn W (1993) Constitutive expression of human BCL-2 modulates nitrogen-mustard-and camptothecin-induced apoptosis. Cancer Res 53:1853-1861